Rosuvastatin calcium and process for producing intermediate thereof
US-2024360086-A1 · Oct 31, 2024 · US
US2018340195A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018340195-A1 |
| Application number | US-201615771799-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 27, 2016 |
| Priority date | Oct 27, 2015 |
| Publication date | Nov 29, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for producing medium chain diol and, more particularly to recombinant microorganisms in which fatty alcohol dehydrogenase and/or fatty alcohol oxidase genes on a ω-oxidative metabolism pathway are deleted, the fatty aldehyde dehydrogenase genes are optionally deleted, and β-oxidative metabolism pathway-related genes are deleted, and to a method for producing medium chain diol from fatty acid-derived alcohol or alkane by culturing the recombinant microorganisms. The recombinant microorganisms of the present invention can produce a high yield of medium chain diol by preventing further oxidation and β-oxidative metabolism of fatty alcohols.
Opening claim text (preview).
1 . A recombinant microorganism from which one or more genes selected from the group consisting of fatty alcohol dehydrogenase and fatty alcohol oxidase genes in an ω-oxidative metabolism pathway are deleted, a fatty aldehyde dehydrogenase gene is optionally deleted, and β-oxidative metabolism pathway-related genes are also deleted. 2 . The recombinant microorganism of claim 1 , wherein the fatty alcohol dehydrogenase gene, the fatty alcohol oxidase gene, the fatty aldehyde dehydrogenase gene, and the β-oxidative metabolism pathway-related genes are deleted from all homologous genes present in the microorganism. 3 . The recombinant microorganism of claim 1 , wherein the fatty alcohol dehydrogenase gene, the fatty alcohol oxidase gene, the fatty aldehyde dehydrogenase gene, and the β-oxidative metabolism pathway-related genes are deleted from some of the homologous genes present in the corresponding microorganism. 4 . The recombinant microorganism of claim 1 , wherein the fatty alcohol dehydrogenase gene is selected from the group consisting of ADH1, ADH2, ADH3, ADH4, ADH5, ADH6, ADH7, ADH8, and FADH genes. 5 . The recombinant microorganism of claim 4 , wherein each of the ADH1, ADH2, ADH3, ADH4, ADH5, ADH6, ADH7, ADH8 and FADH genes comprises base sequences set forth in SEQ ID NOs: 1 to 9, respectively. 6 . The recombinant microorganism of claim 1 , wherein the fatty alcohol oxidase gene is an FAO gene. 7 . The recombinant microorganism of claim 6 , wherein the FAO gene comprises a base sequence set forth in SEQ ID NO: 10. 8 . The recombinant microorganism of claim 1 , wherein the fatty aldehyde dehydrogenase gene is selected from the group consisting of FALDH1, FALDH2, FALDH3, and FALDH4 genes. 9 . The recombinant microorganism of claim 8 , wherein each of the FALDH1, FALDH2, FALDH3, and FALDH4 genes comprises base sequences set forth in SEQ ID NOs: 11 to 14, respectively. 10 . The recombinant microorganism of claim 1 , wherein the β-oxidative metabolism pathway-related gene is an acyl-CoA oxidase gene. 11 . The recombinant microorganism of claim 10 , wherein the acyl-CoA oxidase gene is selected from the group consisting of ACO1, ACO2, ACO3, ACO4, ACO5, and ACO6 genes. 12 . The recombinant microorganism of claim 11 , wherein each of the ACO1, ACO2, ACO3, ACO4, ACO5, and ACO6 genes comprises base sequences set forth in SEQ ID NOs: 15 to 20, respectively. 13 . The recombinant microorganism of claim 1 , wherein the microorganism is a yeast or Escherichia coli. 14 . The recombinant microorganism of claim 13 , wherein the yeast is selected from the group of the yeast consisting of Yarrowia sp., Saccharomyces sp., Pichia sp., and Candida sp. 15 . The recombinant microorganism of claim 14 , wherein the yeast of Yarrowia sp. is Yarrowia lipolytica. 16 . A method for producing a medium chain diol, comprising: (1) preparing the recombinant microorganism according to claim 1 ; and (2) treating the recombinant microorganism with a substrate to culture the recombinant microorganism. 17 . The method of claim 16 , wherein the substrate is selected from the group consisting of a fatty acid-derived alcohol and alkane. 18 . The method of claim 17 , wherein the fatty acid-derived alcohol is an alcohol having 5 to 30 carbon atoms. 19 . The method of claim 17 , wherein the alkane is an alkane having 5 to 30 carbon atoms. 20 . The method of claim 18 , wherein the medium chain diol is a diol compound having 5 to 30 carbon atoms.
for yeasts · CPC title
acting on the CH-CH group of donors (1.3) · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
Acyl-CoA oxidase (1.3.3.6) · CPC title
polyhydric · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.